Schedule an Appointment (424) 248-3134Contact Us

Dr. William F. Stubbeman MDDr. Stubbeman is a certified TMS psychiatrist who has trained with the most prominent TMS physicians in the country including Dr. Sarah H. Lisanby at Duke and Dr. Alvaro Pascual-Leone at Harvard. An experienced and innovative TMS psychiatrist, Dr. Stubbeman administered the most TMS treatments in the nation in year 2011 and has patents pending on several novel brain stimulation protocols for the treatment of tinnitus.

Dr. Stubbeman graduated magna cum laude from Princeton with a degree in Mechanical and Aerospace Engineering and received his MD from Columbia University. He began his training at UCLA as an Ear, Nose and Throat Surgeon specializing in auditory pathology but his growing interest in the brain caused him to switch his focus to Psychiatry.

Upon completion of his residency in 1998, he held a two-year research fellowship at UCLA where he authored a number of scientific publications on early prediction of response to antidepressants and ECT. Dr. Stubbeman subsequently built a thriving psychiatry private practice in West Los Angeles specializing in treatment-refractory psychopharmacology. After realizing the potential of TMS to help patients that were beyond the reach of medications, he expanded the scope of his practice to include TMS treatment.

Dr. Stubbeman’s Research:
  1. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study
    Cook, I. A., Leuchter, A. F., Morgan, M. L., Stubbeman, W., Siegman, B., & Abrams, M. (2005). Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. Journal of psychiatric research, 39(5), 461-466.
  2. Pretreatment neurophysiologic function and ECT response in depression
    Stubbeman, W. F., Leuchter, A. F., Cook, I. A., Shurman, B. D., Morgan, M., Gunay, I., & Gonzalez, S. (2004). Pretreatment neurophysiologic function and ECT response in depression. The journal of ECT, 20(3), 142-144.
  3. Early changes in prefrontal activity characterize clinical responders to antidepressants
    Cook, I. A., Leuchter, A. F., Morgan, M., Witte, E., Stubbeman, W. F., Abrams, M., … & Uijtdehaage, S. H. (2002). Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology, 27(1), 120-131.
  4. Corrigendum to ‘Neurophysiologic predictors of treatment response to fluoxetine in major depression’
    Cook, I. A., Leuchter, A. F., Witte, E., Abrams, M., Uijtdehaage, S. H., Stubbeman, W., … & Dunkin, J. J. (2000). Corrigendum to ‘Neurophysiologic predictors of treatment response to fluoxetine in major depression’:[Psychiatry Research 85 (1999) 263–273] 1PII of original article: S0165-1781 (99) 00010-41. Psychiatry Research, 95(1), 87.
  5. Neurophysiologic predictors of treatment response to fluoxetine in major depression
    Cook, I. A., Leuchter, A. F., Witte, E., Abrams, M., Uijtdehaage, S. H., Stubbeman, W., … & Anderson-Hanley, C. (1999). Neurophysiologic predictors of treatment response to fluoxetine in major depression. Psychiatry research, 85(3), 263-273.
  6. Electromechanical analogs of human reflexes
    Littman, M. G., Liker, M., Stubbeman, W., Russakow, J., McGEE, C., Gelfand, J., & Call, B. J. (1989). Electromechanical Analogs of Human Reflexesa. Annals of the New York Academy of Sciences, 563(1), 184-193.

Or, fill out our form and get help now.

TMS could work for you, let us help you. Contact us today.